Mangoceuticals, Inc. (NASDAQ:MGRX) Stock Short Interest Report for October

Mangoceuticals, Inc. (NASDAQ:MGRX – Get Free Report) was the target of a significant decline in short interest in the month of October. As of October 30th, there was short interest totaling 53,343 shares, a decline of 41.7% from the October 15th total of 91,564 shares. Currently, 0.3% of the shares of the stock are short sold. Based on an average daily trading volume, of 369,429 shares, the short-interest ratio is presently 0.1 days.

Analyst Ratings Changes

A number of research firms have commented on MGRX. Wall Street Zen upgraded Mangoceuticals to a “sell” rating in a research note on Saturday, July 25th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Mangoceuticals in a research report on Monday, September 21st. One analyst has rated the stock with a Sell rating. According to MarketBeat.com, the stock has a consensus rating of “Sell”.

Check Out Our Latest Stock Analysis on Mangoceuticals

Mangoceuticals Trading Down 0.2%

MGRX stock traded down $0.00 during mid-day trading on Tuesday, hitting $0.16. The stock had a trading volume of 409,394 shares, compared to its average volume of 7,674,559. Mangoceuticals has a 52 week low of $0.15 and a 52 week high of $1.38. The firm has a market capitalization of $3.45 million, a P/E ratio of -0.16 and a beta of 2.15. The firm has a fifty day simple moving average of $0.34 and a 200 day simple moving average of $0.39.

Mangoceuticals (NASDAQ:MGRX – Get Free Report) last issued its quarterly earnings results on Monday, November 16th. The company reported ($0.19) earnings per share for the quarter. Mangoceuticals had a negative return on equity of 96.39% and a negative net margin of 4,794.60%. The firm had revenue of $0.07 million for the quarter.

Mangoceuticals Company Profile

(Get Free Report)

Mangoceuticals, Inc. is a men’s health and wellness company that offers telehealth services through its online platform. The platform connects customers with healthcare providers for consultations and, when appropriate, prescription treatments. The company’s offerings have included treatments for erectile dysfunction, hair loss and testosterone-related concerns, as well as weight-management services. Prescriptions are fulfilled through pharmacy partners. Mangoceuticals primarily serves customers in the United States through its digital platform.

See Also

Receive News & Ratings for Mangoceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mangoceuticals and related companies with MarketBeat.com's FREE daily email newsletter.